Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations.
Pediatric neurology · 2021 · 553 citations · Hope Northrup
Early Treatment with Vigabatrin Does Not Decrease Focal Seizures or Improve Cognition in Tuberous Sclerosis Complex: The PREVeNT Trial.
Annals of neurology · 2023 · 72 citations · Hope Northrup
Pegvaliase for the treatment of phenylketonuria: Final results of a long-term phase 3 clinical trial program.
Molecular genetics and metabolism reports · 2024 · 30 citations · Hope Northrup
An ASO therapy for Angelman syndrome that targets an evolutionarily conserved region at the start of the UBE3A-AS transcript.
Science translational medicine · 2023 · 77 citations · Paul Hillman
Safety and Efficacy of DTX401, an AAV8-Mediated Liver-Directed Gene Therapy, in Adults With Glycogen Storage Disease Type I a (GSDIa).
Journal of inherited metabolic disease · 2025 · 22 citations · Heather Saavedra
Efficacy and safety of a synthetic biotic for treatment of phenylketonuria: a phase 2 clinical trial.
Nature metabolism · 2023 · 61 citations · Hope Northrup
Dietetic guidance for nutritional management of people with phenylketonuria receiving sepiapterin.
Molecular genetics and metabolism · 2026 · 6 citations · Paige Roberts
Accumulated seizure burden predicts neurodevelopmental outcome at 36 months of age in patients with tuberous sclerosis complex.
Epilepsia · 2025 · 12 citations · Hope Northrup
Fellowship · Houston, TX
Sponsored by University of Texas Health Science Center at Houston